Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Quote. Real-time Euronext Paris - 01/18 05:39:12 am
2.07 EUR   -0.48%
01/03ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
AQ
01/03European ADRs Move Higher in Monday Trading
MT
2021European ADRs Nudge Lower in Tuesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Erytech Pharma Gets US Patent For Methioninase, Asparaginase in Solid Tumor Treatment

11/29/2021 | 11:33pm EST


ę MT Newswires 2021
All news about ERYTECH PHARMA S.A.
01/03ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
AQ
01/03European ADRs Move Higher in Monday Trading
MT
2021European ADRs Nudge Lower in Tuesday Trading
MT
2021ERYTECH PHARMA S A : ANNOUNCES PRESENTATION OF RESULTS OF EXPANDED ACCESS PROGRAM IN ALL A..
PU
2021Erytech announces $7.85 million registered direct offering
AQ
2021ERYTECH Pharma Expects to Raise $7.9 Million in Direct Offering of Units
MT
2021ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH..
AQ
2021European ADRs Move Sharply Higher in Wednesday Trading
MT
2021European ADRs Move Lower in Tuesday Trading
MT
2021ERYTECH PHARMA S A : Secures US Patent Directed to Sequential Use of Methioninase & Aspara..
PU
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2021 6,74 M 7,67 M 7,67 M
Net income 2021 -61,2 M -69,8 M -69,8 M
Net Debt 2021 16,1 M 18,3 M 18,3 M
P/E ratio 2021 -0,67x
Yield 2021 -
Capitalization 64,5 M 73,6 M 73,5 M
EV / Sales 2021 12,0x
EV / Sales 2022 6,85x
Nbr of Employees 196
Free-Float 67,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 2,08 €
Average target price 4,30 €
Spread / Average Target 107%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-1.89%74
GILEAD SCIENCES, INC.-1.16%90 027
REGENERON PHARMACEUTICALS-2.58%64 327
VERTEX PHARMACEUTICALS6.58%59 510
WUXI APPTEC CO., LTD.-3.73%52 665
BIONTECH SE-23.97%47 338